IMNM: Immunome, Inc. Company Profile & Statistics

Immunome, Inc. Profile

About

Immunome, Inc. is a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome, Inc. is based in Exton, United States.

Info & Links

CEO

Clay Siegall

Headquarters

18702 N. CREEK PARKWAY, SUITE 100
BOTHELL, WA 98011, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

177

Immunome, Inc. Statistics

Valuation Measures

Market Capitalization²

2.33B

Enterprise Value

1.67B

Enterprise Value/EBITDA(ttm)

-7.47

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

186.47

Price to Book(mrq)

3.61

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

-1469.65%

Profit Margin(ttm)

-625.99%

Return on Equity(ttm)

-57.61%

Return on Invested Capital(ttm)

-62.46%

Return on Assets(ttm)

-52.39%

Income Statement

Revenue(ttm)

6.94M

Revenue Per Share(ttm)

0.06

Gross Profit(ttm)

6.94M

EBITDA(ttm)³

-224.00M

Net Income Available to Common(ttm)

-212.39M

Diluted EPS(ttm)

-2.42

Share Statistics

Beta (5Y Monthly)

2.12

52-Week Change

149.14%

S&P 500 52-Week Change

15.40%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

113.13M

Dividend Yield

0.00%

Float⁴

104.43M

% Held by Insiders

7.69%

% Held by Institutions

44.58%

Balance Sheet

Total Cash(mrq)

653.48M

Total Cash Per Share(mrq)

5.78

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

14.69%

Quick Ratio(mrq)

14.69%

Book Value Per Share(mrq)

5.61

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.19

Free Cash Flow(ytd)

-200.60M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

IMNM

Immunome, Inc.